Bolde - 250 by Genesis delivers high-grade Boldenone Undecylenate (commonly known as Equipoise) at an optimal concentration of 250 mg/ml in a multidose 10ml vial. Originally synthesized as a synthetic derivative of testosterone, Boldenone exhibits a structurally modified molecular profile featuring a double bond between carbon positions 1 and 2. This alteration drastically reduces its relative estrogenic conversion while maintaining potent anabolic characteristics. Bodybuilders and performance athletes choose high-purity Boldenone to stimulate consistent nitrogen retention, elevate red blood cell production (erythropoiesis), and achieve steady, dry muscular hypertrophy without excessive subcutaneous water retention.
Boldenone Undecylenate acts directly on androgen receptors to accelerate protein synthesis and prevent cellular catabolism. Due to its long undecylenate ester chain, the active substance is released slowly into systemic circulation from the intramuscular depot, offering prolonged biological activity. Additionally, Bolde - 250 significantly enhances vascularity and muscular endurance via elevated erythropoietin output, delivering greater oxygenation directly to working muscular tissue during intensive training regimens.
Given the long half-life of the undecylenate ester, Bolde - 250 is typically administered once or twice per week via deep intramuscular injection to ensure stable blood plasma levels.
Although aromatization is approximately 50% lower than that of standard testosterone, regular health monitoring is essential. Routine blood tests should track hematocrit, lipid profiles, and liver enzymes. A dedicated Post-Cycle Therapy (PCT) consisting of Clomid and Nolvadex must begin approximately 18 to 21 days following the final injection, once the long undecylenate ester has sufficiently cleared systemic circulation.
Due to the slow-releasing undecylenate ester, peak serum concentrations build gradually. Users typically begin noticing substantial improvements in vascularity, strength, and lean mass around weeks 4 to 6 of the protocol.
No. Boldenone aromatizes to estrogen at half the rate of pure testosterone, producing clean, dry gains. While estrogen control is rarely an issue at moderate doses, sensitive users should keep an aromatase inhibitor on hand.
Boldenone is known for stimulating erythropoiesis, which raises red blood cell volume and hematocrit. Regular complete blood counts (CBC) ensure blood viscosity remains within safe clinical thresholds.
